335
Views
4
CrossRef citations to date
0
Altmetric
Original Articles

Synthesis, anticancer evaluation and in silico ADMET studies on urea/thiourea derivatives from gabapentin

, , , , , & show all
Pages 382-388 | Received 17 Jun 2020, Accepted 30 Oct 2020, Published online: 04 Dec 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Aneela Gohar, Gowhar Ali, Umer Rashid, Khalid Rauf, Mehreen Arif, Muhammad Sona Khan, Yasser MSA Alkahramaan & Robert DE Sewell. (2023) Effect of Gabapentin-Fluoxetine Derivative GBP1F in a Murine Model of Depression, Anxiety and Cognition. Drug Design, Development and Therapy 17, pages 1793-1803.
Read now

Articles from other publishers (3)

Norashikin Roslan, Khairul Bariyyah Abd. Halim, Noraslinda Muhamad Bunnori, Mohd Fadhlizil Fasihi Mohd Aluwi, Karimah Kassim & Nurziana Ngah. (2023) In Silico Study of Thiourea Derivatives as Potential Epidermal Growth Factor Receptor Inhibitors . Journal of Computational Biophysics and Chemistry 22:04, pages 453-472.
Crossref
OMER ERDOGAN, GULEN MELIKE DEMIRBOLAT & OZGE CEVIK. (2023) Raloxifene-loaded and aptamer-bonded exosomes induce autophagic and apoptotic death in HeLa cells by enhancing the lysosomotropic effect. BIOCELL 47:5, pages 1051-1063.
Crossref
Fatih TOK, Cansel ÇAKIR, Dilaycan ÇAM, Mustafa Murat KIRPAT & Yusuf SICAK. (2022) Synthesis, Characterization and Biological Evaluation of Novel Thiourea Derivatives. Clinical and Experimental Health Sciences 12:2, pages 533-540.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.